QuidelOrtho (QDEL) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

QDEL Stock Forecast


QuidelOrtho (QDEL) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $35.00, with a high of $35.00 and a low of $35.00. This represents a 30.65% increase from the last price of $26.79.

$25 $35 $45 $55 $65 $75 High: $35 Avg: $35 Low: $35 Last Closed Price: $26.79

QDEL Stock Rating


QuidelOrtho stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (46.67%), 6 Hold (40.00%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Buy
Total 15 2 6 7 0 Strong Sell Sell Hold Buy Strong Buy

QDEL Price Target Upside V Benchmarks


TypeNameUpside
StockQuidelOrtho30.65%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks16.76%

Price Target Trends


1M3M12M
# Anlaysts111
Avg Price Target$35.00$35.00$35.00
Last Closing Price$26.79$26.79$26.79
Upside/Downside30.65%30.65%30.65%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26123-17
Dec, 25123-17
Nov, 25123-17
Oct, 25132-17
Sep, 25232-18
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 21, 2026UBS$35.00$32.736.94%30.65%
Sep 19, 2024Lu LiUBS$50.00$46.238.15%86.64%
Sep 05, 2024Bill BonelloCraig-Hallum$57.00$42.9332.77%112.77%
Aug 15, 2023Andrew CooperRaymond James$110.00$74.4747.71%310.60%
Dec 12, 2022Citigroup$125.00$92.3035.43%366.59%
Dec 07, 2022RBC Capital$125.00$92.1935.59%366.59%
Oct 14, 2022Elizabeth GarciaUBS$86.00$76.3812.59%221.02%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 21, 2026UBSNeutralNeutralhold
Oct 07, 2025CitigroupBuyNeutraldowngrade
Dec 11, 2024CitigroupBuyBuyupgrade
Sep 19, 2024UBSBuyBuyhold
Sep 19, 2024UBSNeutralupgrade
Sep 05, 2024Craig-HallumBuyupgrade
May 09, 2024RBC CapitalOutperformOutperformhold
Apr 02, 2024William BlairMarket PerformMarket Performhold
Apr 02, 2024RBC CapitalOutperformOutperformhold
Feb 14, 2024Raymond JamesStrong BuyOutperformdowngrade

Financial Forecast


EPS Forecast

$-35 $-24 $-13 $-2 $9 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.74$9.66$-0.15$-30.16----
Avg Forecast$16.12$14.19$5.01$1.81$2.45$3.34$4.55$5.45
High Forecast$16.34$14.41$5.21$1.91$2.75$16.96$4.64$5.56
Low Forecast$15.90$13.99$4.87$1.74$2.20$-10.29$4.47$5.36
Surprise %3.85%-31.92%-102.99%-1766.30%----

Revenue Forecast

$2B $2B $3B $3B $4B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.70B$3.27B$3.00B$2.78B----
Avg Forecast$1.57B$3.78B$3.05B$2.77B$2.76B$2.87B$3.00B$3.13B
High Forecast$1.59B$3.82B$3.08B$2.82B$2.80B$2.88B$3.05B$3.18B
Low Forecast$1.56B$3.74B$3.04B$2.76B$2.72B$2.87B$2.96B$3.09B
Surprise %7.89%-13.58%-1.78%0.32%----

Net Income Forecast

$-3B $-2B $-700M $200M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$704.20M$548.70M$-10.10M$-2.03B----
Avg Forecast$1.31B$1.44B$-10.10M$121.83M$165.34M$-2.43M$303.94M$364.06M
High Forecast$1.57B$1.72B$-8.08M$127.63M$183.41M$1.13B$309.97M$371.28M
Low Forecast$1.05B$1.15B$-12.12M$116.03M$147.26M$-687.69M$298.77M$357.87M
Surprise %-46.12%-61.77%--1763.84%----

QDEL Forecast FAQ


Is QuidelOrtho stock a buy?

QuidelOrtho stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 6 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that QuidelOrtho is a favorable investment for most analysts.

What is QuidelOrtho's price target?

QuidelOrtho's price target, set by 15 Wall Street analysts, averages $35 over the next 12 months. The price target range spans from $35 at the low end to $35 at the high end, suggesting a potential 30.65% change from the previous closing price of $26.79.

How does QuidelOrtho stock forecast compare to its benchmarks?

QuidelOrtho's stock forecast shows a 30.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (16.76%).

What is the breakdown of analyst ratings for QuidelOrtho over the past three months?

  • January 2026: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.
  • December 2025: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.
  • November 2025: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.

What is QuidelOrtho’s EPS forecast?

QuidelOrtho's average annual EPS forecast for its fiscal year ending in December 2025 is $2.45, marking a -108.12% decrease from the reported $-30.16 in 2024. Estimates for the following years are $3.34 in 2026, $4.55 in 2027, and $5.45 in 2028.

What is QuidelOrtho’s revenue forecast?

QuidelOrtho's average annual revenue forecast for its fiscal year ending in December 2025 is $2.76B, reflecting a -0.77% decrease from the reported $2.78B in 2024. The forecast for 2026 is $2.87B, followed by $3B for 2027, and $3.13B for 2028.

What is QuidelOrtho’s net income forecast?

QuidelOrtho's net income forecast for the fiscal year ending in December 2025 stands at $165.34M, representing a -108.16% decrease from the reported $-2.027B in 2024. Projections indicate $-2.434M in 2026, $303.94M in 2027, and $364.06M in 2028.